Literature DB >> 20813526

Synthesis and biological evaluation of a novel series of bis-salicylaldehydes as mushroom tyrosinase inhibitors.

Giovanna Delogu1, Gianni Podda, Marcella Corda, Maria Benedetta Fadda, Antonella Fais, Benedetta Era.   

Abstract

A series of novel bis-salicylaldehydes were synthesised and evaluated as tyrosinase inhibitors using a tyrosinase-dependent L-DOPA oxidation assay. The bis-salicylaldehydes exhibited greater inhibitory activity than salicylaldehyde. Our data suggests that these novel compounds may serve as a structural template for the design and development of novel tyrosinase inhibitors.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20813526     DOI: 10.1016/j.bmcl.2010.08.018

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  5 in total

1.  A theoretical study of benzaldehyde derivatives as tyrosinase inhibitors using Ab initio calculated NQCC parameters.

Authors:  Marjan Rafiee; Masoumeh Javaheri
Journal:  Mol Biol Res Commun       Date:  2015-09

2.  2,4-Bis[(prop-2-yn-yl)-oxy]benzaldehyde.

Authors:  M Esakkiammal; V Selvarani; M A Neelakantan; V Silambarasan; D Velmurugan
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-07-18

3.  The Effect of D-(-)-arabinose on Tyrosinase: An Integrated Study Using Computational Simulation and Inhibition Kinetics.

Authors:  Hong-Jian Liu; Sunyoung Ji; Yong-Qiang Fan; Li Yan; Jun-Mo Yang; Hai-Meng Zhou; Jinhyuk Lee; Yu-Long Wang
Journal:  Enzyme Res       Date:  2012-12-23

4.  2-Hy-droxy-4-(prop-2-yn-yloxy)benz-alde-hyde.

Authors:  V Selvarani; M A Neelakantan; V Silambarasan; D Velmurugan
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-12-08

5.  1-[2-Hy-droxy-4-(prop-2-yn-1-yl-oxy)phen-yl]ethanone.

Authors:  V Selvarani; M A Neelakantan; T Srinivasan; D Velmurugan
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-12-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.